Global Custom Market Research Reports Provider Company

phone

AstraZeneca K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 13 Mar 2015
  • Number of Pages: 21
  • Category: Healthcare and Medical
  • Country: Japan
Summary

AstraZeneca K.K. (AstraZeneca) is a biopharmaceutical company which develops, manufactures, and markets prescription drugs. The company offers akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for use in the therapeutic areas of cancer, cardiovascular, digestive, respiratory, diabetes and neuroscience. AstraZenecas research organization creates small molecule and biologics biotech units in the form of innovative medicines. The company has its presence in its presence in Sapporo, Tokyo, Saitama, Osaka, Hiroshima and Fukuoka. AstraZeneca is headquartered in Osaka, Japan.

AstraZeneca K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData
List of Tables 3
List of Figures 4
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
AstraZeneca K.K., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 10
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 12
AstraZeneca Enters Into Co-Promotion Agreement With Daiichi Sankyo For Denosumab 13
AstraZeneca Enters Into Co-Promotion Agreement With Daiichi Sankyo For Eesomeprazole 14
Acquisition 15
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 15
AstraZeneca K.K. - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables

AstraZeneca K.K., Pharmaceuticals & Healthcare, Key Facts 1
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
AstraZeneca K.K., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
AstraZeneca K.K., Deals By Therapy Area, 2009 to YTD 2015 8
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 10
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 12
AstraZeneca Enters Into Co-Promotion Agreement With Daiichi Sankyo For Denosumab 13
AstraZeneca Enters Into Co-Promotion Agreement With Daiichi Sankyo For Eesomeprazole 14
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 15
AstraZeneca K.K., Key Competitors 17
AstraZeneca K.K., Key Employees 18
AstraZeneca K.K., Other Locations 19

List Of Figures

AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
AstraZeneca K.K., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

AstraZeneca KK (AstraZeneca), a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other

View Report

AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its

View Report

AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas of cardiovascular

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports